These Analysts Revise Their Forecasts On Wave Life Sciences Following Q3 Results - WAVE Life Sciences (NASDAQ:WVE)

Wave Life Sciences Ltd (NASDAQ:WVE) reported worse-than-expected third-quarter financial results on Monday.WAVE Life Sciences reported quarterly losses of 32 cents per share which missed the analyst consensus estimate of losses of 30 cents per share. The company reported quarterly sales of $7.608 million which missed the analyst consensus estimate of $11.130 million.“In the third quarter, we achieved key clinical objectives with WVE-007 for obesity and WVE-006 for alpha-1 antitrypsin deficiency, which valid ...